Search results :

Topiramate

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N03AX11

Side effects

Options: Show MedDRA Preferred Terms,   display all 68 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Neuropathy peripheral 2% - 32% 15% x x x x x x x x x x x x x x x x x x x
Headache postmarketing — 1% - 29% x
Upper respiratory tract infection 12% - 36.7% 12% x x x x x x x x x x x x x x x x x x x
Nervousness 0% - 19.3% 2% - 7.4% x x x x x x x x x x x x x x x x x x
Vaginal inflammation 13% x x x x x
Fatigue postmarketing — 1% - 30.7% 4% - 13.4% x x x x x x x x x x x x x x x x x x x
Nystagmus 6.1% - 15% 6.8% - 9.3% x x x x x x x x x x x x x x x x x
Abnormal behaviour 0% - 11.2% 3.9% - 9% x x x x x x x x x x x x x x x x x x
Irritability 2% - 14.6% 1% - 8.8% x
Anorexia postmarketing — 2% - 24.5% 1% - 15% x x x x x x x x x x x x x x x x x x x
Malnutrition postmarketing, 6% - 21% 3% - 4% x x x x x x x x x x x x x x x x x x x
Somnolence postmarketing — 0% - 30.1% 2% - 16% x x x x x x x x x x x x x x x x x x x
Purpura 4% - 8.2% 4% x x x x x x x x x x x x x x x x x
Taste disorders 2% - 15% 0% x x x
Weight decreased postmarketing — 2.5% - 31% 0% - 4.2% x x x x x x x x x x x x x x x x x x x
Disturbance in attention 2.6% - 11.9% 1.8% - 2.3%
Insomnia very rare — 0% - 14% 3% - 7% x x x x x x x x x x x x x x x x x x x
Depression rare, 0% - 13% 3.4% - 6% x x x x x x x x x x x x x x x x x
Dizziness postmarketing, 0% - 34.1% 2% - 15.3% x x x x x x x x x x x x x x x x x x x
Paraesthesia postmarketing — 0% - 51% 0% - 6% x x x x x x x x x x x x x x x x x x x
Cerebration impaired postmarketing, 0% - 15% 0% - 2% x x x x x x x x x x x x x x
Lethargy 1.2% - 13.5% 2.1% - 8.8%
Abdominal pain very rare — 1.1% - 15% 0.8% - 5% x x x x x x x x x x x x x x x x x
Nausea postmarketing — 0% - 15.1% 5% - 8.4% x x x x x x x x x x x x x x x x x x x
Salivary hypersecretion 4% - 6.1% 4% x x x x x x x x x x x x x x x x x
Viral infection 1% - 15% 1% - 3% x x x x x x x x x x x x x x x x x
Decreased appetite 1.3% - 19.2% 2% - 12.7%
Anaemia frequent, 0.8% - 3% x x x x x x x x x x x x x x x x x x x x
Arthralgia postmarketing — 1% - 7% 2% x x x x x x x x x x x x x x x x x x
Conjunctivitis frequent, 0% - 7% 1% x x x x x x x x x x x x x x x x x x x
Diarrhoea very rare — 2% - 14% 1% - 5.2% x x x x x x x x x x x x x x x x x x x
Hallucination very rare — frequent x x x x x x x x x x x x x x x x x x
Pain 2.9% - 6.2% 4.2% x x x x x x x x x x x x x x x x x x x
Pharyngitis 2% - 21% 2% - 4% x x x x x x x x x x x x x x x x x
Pneumonia 1% - 5.1% 1% x x x x x x x x x x x x x x x x x
Psychotic disorder very rare — frequent x x x x x x x x x x x x x x x x x x x
Sinusitis 1% - 15% 4% - 6% x x x x x x x x x x x x x x x x x
Suicide attempt postmarketing — frequent x x x x x x x x x x x x x x x x x x x
Syncope infrequent — 1% x x x x x x x x x x x x x x x x x x x
Erectile dysfunction frequent, 1% - 2% x x x x x x x x x x x x x x x x x x x
Hyperkinesia postmarketing, 0% - 21% 4% x x x x x x x x x x x x x x x x
Vomiting very rare — 1% - 14% 2% x x x x x x x x x x x x x x x x x x x
Bradyphrenia 0% - 19.5% 1.4% - 3.1%
Expressive language disorder postmarketing, 3.5% - 9.4% 1.4% - 1.6% x
Anxiety 0% - 10.4% 1.8% - 6% x x x x x x x x x x x x x x x x x x x
Asthenia very rare — 0% - 8% 1% - 1.8% x x x x x x x x x x x x x x x x x
Ataxia postmarketing, 1% - 21.2% 1% - 7% x x x x x x x x x x x x x x x x x x x
Confusional state very rare — 0% - 14% 0.8% - 5% x x x x x x x x x x x x x x x x x x x
Constipation 0% - 7% 0% - 4.9% x x x x x x x x x x x x x x x x x
Dysarthria 1.6% - 6.2% 1%
Dyspepsia 0% - 8% 0% - 6.5% x x x x x x x x x x x x x x x x x
Breast pain 0% - 8.3% 1.7% - 2% x x x x x x x x x x x x x x x
Rhinitis 0% - 21% 0% - 6.9% x x x x x x x x x x x x x x x x x
Speech disorder very rare — 1% - 16.8% 0.5% - 2.3% x x x x x x x x x x x x x x x x x x x
Coordination abnormal 3.6% - 11.4% 1.9% - 4.2% x x x x x x x x x x x x x x x x x
Action tremor 3.1% - 4.8% 2.9%
Abdominal pain upper 3.7% - 3.9% 2.1%
Balance disorder 0.4% - 5.8% 0% - 2.4%
Amnesia very rare — 2.9% - 5.3% 0.5% - 1% x x x x
Dysmenorrhoea 0% - 8.3% 6.8% x x x x x x x x x x x x x x x x x x
Upset stomach 1% - 3.2% 0.2% - 1.3%
Convulsions aggravated 3% - 3.1% x x x x x x x x x x x x x x x x x x x
Bronchitis 0% - 7% 2% x x x x x x x x x x x x x x x x x
Dysgeusia very rare — 0% - 15.4% 0% - 1% x x x x x x x x x x x x x x x x
Gastroenteritis 0% - 7% 1% - 2% x x x x x x x x x x x x x x x x x
Skin disorder 1% - 3.1% 1% - 2% x x x x x x x x x x x x x x x x x x
Tremor 0% - 10.6% 1.4% - 6% x x x x x x x x x x x x x x x x x
Agitation postmarketing — 1% - 4.4% 1% - 2% x x x x x x x x x x x x x x x x x
Mood swings postmarketing, 0% - 5.1% 0.2% - 2% x x x x x x x x x x x x x x
Influenza-like symptoms 0% - 7% 1% - 3.2% x x x x x x x x x x x x x x x x x
Gait disturbance 0% - 8% 1% - 5% x x x x x x x x x x x x x x x x x x
Aggressive reaction 0% - 9.2% 0% - 4% x x x x x x x x x x x x x x x x x x x
Hypoaesthesia 1% - 8% 0% - 2% x x x x x x x x x x x x x x x x x
Disorientation 1.7% - 3.2% 1%
Convulsion postmarketing — 1% - 2.3% 0% x x x x x x x x x x x x x x x x x x x
Muscle spasms 1.7% - 3.3% 0.8%
Alopecia postmarketing — 0% - 6.3% 1% x x x x x x x x x x x x x x x x x
Amenorrhoea 2% 1% x x x x x x x x x x x x
Aphasia 2% 0%
Back pain 0% - 6.2% 0% - 4.2% x x x x x x x x x x x x x x x x x
Chest pain 1% - 4.4% 1% - 3% x x x x x x x x x x x x x x x x x
Infection postmarketing, 0% - 14% 1% - 13% x x x x x x x x x x x x x x x x x
Cough 0% - 7% 2% x x x x x x x x x x x x x x x x x x x
Cystitis 0% - 3% 0% x x x x x x x x x x x x x x x x
Dermatitis 0% - 7% 0% x x x x x x x x x x x x x x x x x
Diplopia 0% - 12.1% 0% - 5% x x x x x x x x x x x x x x x x x x x
Oedema postmarketing, 1% - 2% 1% x x x x x x x x x x x x
Epistaxis 0% - 8% 0.5% - 1% x x x x x x x x x x x x x x x x x
Congenital eye disorder 1% - 2% 1% x x x x x x x x x x x x x x x x x
Body temperature increased very rare — 0% - 12% 1% x x x x x x x x x x x x x x x x x x x
Haematuria 0% - 2% 1% x x x x x x x x x x x x
Hypersensitivity 0% - 7% 1% x x x x x x x x x x x x
Hypertrichosis 1% - 2% 1% x x x x x x x x x x x x x x x x x
Cramps of lower extremities 0% - 2% 0% x x x x x x x x x x x x x x x x x
Leg pain 1% - 8% 2% - 2.3% x x x x x x x x x x x x x x x x x
Leukopenia postmarketing, 0% - 2.7% 0% - 1% x x x x x x x x x x x x x x x x
Leukorrhea 2% 0% x x x x x x x x x x x x x x x x
Menorrhagia 1% - 2% 0% x x x x x x x x x x x x x x x x x
Menstrual disorder 0.8% - 4.2% 0% - 2% x x x x x x x x x x x x x x x x
Otitis media 0% - 8% 1% x x x x x x x
Prostatic disorder 0% - 2.2% 1% - 0.6% x x x x x x x x x x x x x x x x
Tachycardia 2% x x x x x
Thirst 1% - 2% 1% x x x x x x x x x x x x x x x x x
Tinnitus 0.4% - 2% 0% - 1% x x x x x x x x x x x x x x x x
Urinary incontinence 1% - 4.1% 1% - 2% x x x x x x x x x x x x x x x x x
Urinary tract infection 0% - 5% 1% - 2% x x x x x x x x x x x x x x x x x
Urinary tract disorder postmarketing, 0% - 4.1% 0% x x x x x x x x x x x x x x x x x x x
Disorder sight 0% - 13% x x x x x x x x x x x x x x x x x x x
Dry mouth 0.4% - 5% 0% - 2.5% x x x x x x x x x x x x x x x x x
Stupor 1% - 2% 0% x x x x x x x x x x x x
Oedema peripheral 2% x x x x x
Hyporeflexia 0% - 2% 0% x x x x x x x x x x x x x x x x x
Myalgia postmarketing, 2% - 2.5% 1% - 1.3% x x x x x x x x x x x x x x x x x
Rash erythematous 0% - 8% 0% - 1% x x x x x x x x x x x x x x x x x
Muscle contractions involuntary 0% - 8% 1% x x x x x x x x x x x x x x x x x
Vision blurred postmarketing — 2% - 8.9% 2% - 2.5% x x x x x x x
Depressed mood 0.4% - 2.9% 0.9%
Psychomotor retardation 2% 0%
Hot flush postmarketing, 0.7% - 2.7% 1% - 1.9% x x x x x x x x x x x x x x x x x
Acne 0% - 3% x x x x x x x x x x x x x x x
Hearing impaired 1% - 2% 1% x x x x x x x x x x x
Abnormal vision 0% - 14.2% 0% - 2% x x x x x x x x x x x x x x x x x x x
Anger 1.7% - 2.1% 0.5%
Depersonalisation 1% - 2.2% 0.9% - 1% x x x x x x x x x x x x x x x x
Apathy 1% - 3.1% 0% - 1% x x x x x x x x x x x x x x x x x
Paraesthesia oral 1.2% - 3.3% 0.5%
Learning disability 0% - 3.2%
Coagulopathy 1% - 2% 1% x x x x x x x x x x x x x x x x x x x
Cardiovascular disorder 1% - 2% 0% x x x x x x x x x x x x x x
Haemorrhage 1% - 2% 1% x x x x x x x x x x x x x x x x x x x
Red blood cell disorders 1% - 2% x x x x x x x x x x x x x x x x x x x
Auditory disorder NOS 1% - 2% 1% x x
Musculoskeletal chest pain 1.1% - 1.8% 0.3%
Mental disability 0.4% - 5% 0.9% - 1.3%
Personality disorder 0% - 11.2% 9% x x x x x x x x x x x x x x x x x x x
Muscle twitching 0.4% - 1.8% 0.7%
Cognitive disorder 0.4% - 2%
Memory impairment postmarketing, 1.2% - 10.8% 1% - 1.8% x x x
Hypoaesthesia facial 0.4% - 2%
Candida infection 0% - 1% 0% - 1% x x x x x x x x x x x
Libido decreased 0% - 3% 1% x x x x x x x x x x x x x x x x x
Dysphagia 1% 0% x x x x x x x x x x x x
Dyspnoea 1% - 6% 0.9% - 2% x x x x x x x x x x x x x x x x
Eczema 0% - 1% 0% x x x x x x x x x x x x
Grand mal convulsion 0% - 7% 0% x x x x x x x x x x x x
Rash very rare — 0.4% - 6.7% 1% - 5.9% x x x x x x x x x x x x x x x x x x x
Faecal incontinence 0% - 1% 0% x x x x x x x x x x x x
Flatulence 1% 0% x x x x x x x x x x x x
Gastrooesophageal reflux disease 0.4% - 2% 0% - 0.5% x x x x x x x x x x x x x x x x
Gingival hyperplasia 1% 0% x x x x x x x x x x x
Gingivitis 1% 1% x x x x x x x x x x x x
Glossitis 1% 0% x x x x x x x x x x x x
Haematoma 0% - 2% 0% x x x x x x x x x x x x x x x x
Hypertension 1% - 3% 0% - 1% x x x x x x x x x x x
Hypoglycaemia 0% - 1% 0% x x x x x x x x x x x x
Myopia very rare — 0% - 1% 0% x x x x x x x x x x x x x x x x
Neurosis infrequent, 1% 0% x x x x x x x x x x x
Nocturia 0% - 1% 0% x x x x x x x x x x x
Pallor 1% 0% x x x x x x x x x x x
Pruritus 0% - 4% 2% x x x x x x x x x x x x x x x x
Seborrhoeic dermatitis 0% - 1% 0% x x x x x x x x x x x x
Thrombocytopenia postmarketing, 1% 0% x x x x x x x x x x x x x x x
Toothache 1% - 7% x x x x x
Pollakiuria 0% - 4% 1% x x x x x x x x x x x x x x x x x
Vertigo 0% - 3.2% 1% x x x x x x x x x x x x x x x x
Weight increased postmarketing, 0% - 1% 0% x x x x x x x x x x x x x x x
Body odor 0% - 1% 0% x x x x x x x x x x x x
Migraine postmarketing, 0% - 2% x x x
Gamma-glutamyltransferase increased infrequent, 1% - 3% x x x x x x x x x x x
Muscular weakness frequent, 1% x x x x x x x x x x x x x x x x x x x
Bone pain 0% - 1% 0% x x x x x x x x x x x
Prothrombin level increased 1% 0% x x x x x x x x x x x x
Skin discolouration 0% - 1% 0% x x x x x x x x x x x
Increased appetite 1% 0% x x x x x x x x x x x x
Urine abnormality 0% - 1% 0% x x x x x x x x x x x
Depression aggravated 1% - 3% 1% x x x x x x x
Lacrimation abnormal NOS 0% - 1% 0% x x x x x x x x x x x x
Rash maculo-papular 0% - 2% x x x x x
Rigors 1% 0% x x x x x x x x x x x
Bradycardia 1% 0% x x x x x x x x x x x
Sweating increased 1% - 2% 1% x x x x x x x x x x x x x x x x x
Psychomotor skills impaired 0% - 2%
Dysphasia 1% 0%
Ear pain 0% - 1.3% x x x x x
Dry eye 0% - 1.3%
Pruritus generalised 0% - 1.3%
Rhinorrhoea 0% - 1.3%
Agranulocytosis infrequent x x x x x x x x x x x x x x
Albuminuria infrequent x x x x x x x x x x x x x x
Angina pectoris infrequent x x x x x x x x x x x x x x
Apraxia infrequent x x x x x x x x x x x x x x
Atrioventricular block infrequent x x x x x x x x x x x x x x
Dehydration postmarketing — frequent x x x x x x x x x x x x x x x x x x
Delirium infrequent x x x x x x x x x x x x x x
Delusion postmarketing, infrequent x x x x x x x x x x x x x x x x x x
Diabetes mellitus rare, infrequent x x x x x x x x x x x x x x
Dyskinesia infrequent x x x x x x x x x x x x x x x x x x x
Eosinophilia infrequent x x x x x x x x x x x x x x
Oesophagitis infrequent x x x x x x x x x x x x x x
Flushing postmarketing — 0% - 5% x x x x x x x x x x x x x x x x x x x
Gastritis infrequent, 0% - 3% x x x x x x x x x x x x x x x x x x x x
Gingival bleeding infrequent, 0% - 1.3% x x x x x x x x x x x x x x
Haemorrhoids infrequent, frequent x x x x x x x x x x x x x x x x x x x
Hyperaesthesia infrequent x x x x x x x x x x x x x x
Hyperglycaemia infrequent x x x x x x x x x x x x x x
Hyperlipidaemia infrequent x x x x x x x x x x x x x x
Hypocalcaemia infrequent x x x x x x x x x x x x x x
Hypokalaemia postmarketing, infrequent x x x x x x x x x x
Hypotension infrequent x x x x x x x x x x x x x x
Orthostatic hypotension infrequent x x x x x x x x x x x x x x
Arthropathy infrequent x x x x x x x x x x x x x x
Lymphopenia infrequent x x x x x x x x x x x x x x
Melaena infrequent x x x x x x x x x x x x x x
Oliguria infrequent x x x x x x x x x x x x x x
Phlebitis infrequent x x x x x x x x x x x x x x
Polyuria infrequent x x x x x x x x x x x x x x
Pulmonary embolism rare, infrequent x x x x x x x x x x x x x x
Scotoma infrequent, 0.4% - 1.3% x x x x x x x x x x x x x x
Stomatitis infrequent x x x x x x x x x x x x x x
Urticaria infrequent, frequent x x x x x x x x x x x x x x
Vasodilation infrequent x x x x x x x x x x x x x x
Xerophthalmia infrequent x x x x x x x x x x x x x x
Urinary retention infrequent x x x x x x x x x x x x x x
Encephalopathy postmarketing, infrequent x x x x x x x x x x x x x x x x x
Photophobia infrequent x x x x x x x x x x x x x x
Breast discharge infrequent x x x x x x x x x x x x x x
Deep vein thrombosis infrequent x x x x x x x x x x x x x x
Electroencephalogram abnormal infrequent x x x x x x x x x x x x x x
Paranoid reaction infrequent x x x x x x x x x x x x x x
Phosphatase alkaline increased infrequent x x x x x
Aspartate aminotransferase increased infrequent x x x x x x x x x x x x x x
Alanine aminotransferase increased infrequent x x x x x x x x x x x x x x
Accommodation disorder infrequent x x x x x x x x x x x x x x x x x x
Photosensitivity reaction infrequent x x x x x x x x x x x x x x
Euphoric mood infrequent, frequent x x x x x x x x x x x x x x
Hair texture abnormal infrequent x x x x x x x x x x x x x x
Ejaculation disorder infrequent x x x x x x x x x x x x x x
Enlargement abdomen infrequent x x x x x x x x x x x x x x
Neuropathy infrequent x x x x x x x x x x x x x x
Lymphadenopathy infrequent x x x x x x x x x x x x x x
Face oedema infrequent x x x x x x x x x x x x x x
Renal pain infrequent x x x x x x x x x x x x x x
Thrombocytosis infrequent x x x x x x x x x x x x x x
Paranoia infrequent x x x x x x x x x x x x x x
Parosmia infrequent x x x x x x x x x x x x x x
Dysphonia infrequent x x x x x x x x x x x x x x
Ageusia infrequent, 1% - 2% 1% x x x x x x x x x x x x x x x x x x
Neoplasm 1% - 2% 1% x x x x x x x x x x x x x x x x x
Affect lability 0.2% - 1.1% 0.2%
Abdominal distension 0% - 1.3% 0.2%
Renal tubular acidosis very rare, postmarketing x x x x
Aggression very rare — 2.8% - 8.7% 1.8% - 6.9% x
Mental disorder postmarketing x x x x x x x x x x x x x x x x x x x
Bipolar disorder postmarketing x
Cerebellar syndrome rare x x x x x x x x x x x x x x
Connective tissue disorder postmarketing x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x
Epilepsy postmarketing x
Erythema multiforme postmarketing x x x x x x x x x x x x x x x
Eye disorder postmarketing x
Angle closure glaucoma very rare, postmarketing x x x x
Hepatitis postmarketing x x x x x x x x x x x x x x x
Hypernatraemia rare x x x x x x x x x x x x x x
Hypohidrosis postmarketing x x x x x x x x x x
Hyponatraemia rare x x x x x x x x x x x x x x
Immune system disorder postmarketing
Libido increased rare, infrequent x x x x x x x x x x x x x x
Iritis rare x x x x x x x x x x x x x x
Lymphocytosis rare x x x x x x x x x x x x x x
Chloasma rare x x x x x x x x x x x x x x
Musculoskeletal pain postmarketing x
Mydriasis rare, infrequent x x x x x x x x x x x x x x x x x x
Nasopharyngitis postmarketing
Nervous system disorder postmarketing x x x x x
Neutropenia very rare, postmarketing x
Eye movement disorder postmarketing
Pancreatitis postmarketing x x x x x x x x x x x x x x
Pancytopenia rare x x x x x x x x x x x x x x
Pemphigus postmarketing x x x x x x x x x x x x x x x
Polycythaemia rare x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Suicide postmarketing x x x x
Hepatic failure postmarketing x x x x x x x x x x x x x x x
Vasospasm rare x x x x x x x x x x x x x x
Hyperchloraemia rare, infrequent x x x x x x x x
Hypophosphataemia rare x x x x x
Periorbital oedema postmarketing
Alcohol intolerance rare x x x x x x x x x x x x x x
Creatinine increased rare x x x x x x x x x x x x x x x
Generalised oedema postmarketing
Tongue oedema rare, infrequent x x x x x x x x x x x x x x
Hypocholesterolaemia rare x x x x x x x x x x x x x x
Manic psychosis rare, infrequent x x x x x x x x x x x x x x
Bone marrow depression rare x x x x x x x x x x x x x x
Eye pain very rare, postmarketing x x x x x x x x x x x x x x x x x x x
Joint swelling postmarketing
Eyelid oedema postmarketing
Unspecified disorder of skin and subcutaneous tissue postmarketing x
Metabolic acidosis very rare, postmarketing x x x x x x x x x x x
Hyperammonaemia postmarketing x x x x x x x x
Heat intolerance postmarketing x
Feeling of despair postmarketing
Tongue paralysis rare x x x x x x x x x x x x x x
Eye redness postmarketing x x x x
Upper motor neurone lesion rare, infrequent x x x x x x x x x x x x x x
Hepatic enzyme increased postmarketing x
Nephrolithiasis postmarketing — 0% - 2.6%
Suicidal ideation very rare, postmarketing x x x x
Abnormal sensation in eye postmarketing
Influenza like illness postmarketing
Visual disturbance postmarketing — 1.4% - 2% 0.3% x x x x
Sweating decreased postmarketing, infrequent x x x x x
Drug interaction postmarketing
Maculopathy postmarketing x x x x x x x x x x x
Allergic oedema postmarketing
Infestation NOS postmarketing
Blood and lymphatic system disorders postmarketing x
Completed suicide postmarketing x x x x x
Limb discomfort postmarketing
Attention concentration difficulty postmarketing x x x x x x x x x x x x x x x x x x x
Feeling abnormal very rare, postmarketing x
Pancreatitis acute very rare
Blindness transient very rare
Acidosis postmarketing — 0% - 7% x x x x x x x
Respiratory alkalosis x
Amblyopia x x x
Anhidrosis
Anosmia
Asthma 0% - 2% x x x x x x x
Blepharospasm
Clotting x
Breast disorder
Calcinosis
Collagen disorder x x x x x
Deafness
Dermatitis atopic
Drooling
Drug abuse
Dysuria frequent, 0% - 2% x x x x x x x x x x x x x x x x
Effusion x x x x
Endocrine disorder
Flank pain
Formication
Gastrointestinal disorder postmarketing, 0% - 7% x x x x
Glaucoma x x x
Glossodynia
Breath odour
Deafness neurosensory
Cardiac disorder
Hyperplasia
Hyperthyroidism 0% - 8%
Body temperature decreased x x x x x x
Incontinence
Calculus of kidney frequent, 0% - 7% 0% x x x x x x x x x x x x x x x
Nephropathy x
Laryngitis 0% - 8%
Mastitis 0% - 2% x x x x x
Mediastinal disorder
Metrorrhagia 0% - 3% x x x x x x x x x x
Hypertonia frequent, 0% - 7% x x x x x x x x x x x x x x x x
Nail disorder 0% - 2% x x x x x
Nasal congestion
Night blindness
Obesity x x x x
Osteomalacia x
Palpitations x x x x x
Panic reaction
Panic disorder
Pemphigoid
Premature ejaculation 0% - 3% 0% x x x x x x x
Presbyopia
Renal failure x x x x
Respiratory tract infection x
Rickets x
Status epilepticus x
Ulcerative stomatitis x x x x x
Testicular disorder x x x x x
Tooth disorder x x x x x
Unintended pregnancy x x x x
Erythema
Angiopathy x x x x x
Acidosis hyperchloraemic
Polydipsia
Micturition urgency
Sinus bradycardia
Akinesia
Burning sensation
Photopsia
Hypokinesia
Panic attack
Conjunctival oedema
Swelling face
Hypogeusia
Sensory disturbance x x x x x x
Renal colic
Lacrimation increased
Ocular hyperaemia x x x x
Rash macular
Oral pain
Malaise
Dyspnoea exertional
Abdominal discomfort
Abdominal pain lower
Abdominal tenderness
Distractibility
Flat affect
Elevated mood
Thinking abnormal x x x
Perseveration
Hallucination, auditory
Hallucination, visual
Clumsiness
Anorgasmia
Dysgraphia
Visual acuity reduced x x x x
Intraocular pressure increased x x x x
Skin odour abnormal
Dizziness postural
Scintillating scotoma
Migraine aggravated x x x x x x
Aura
Pharyngeal oedema 0% - 8%
Diabetic x
Hypomania
Drug - food interaction x
Muscle fatigue
Ketogenic diet x
Essential tremor
Blindness unilateral
Peripheral coldness
Sensory loss
Redness x x x x
Cognitive impairment x x
Mania
Anxiety depression x x
Genital candidiasis x x x x x x
Repetitive speech
Dysaesthesia
Initial insomnia
Middle insomnia
Tearfulness
Fluid intake increased x x x x
Bicarbonate level x x x
Dependence
Word finding difficulty x
Dyslexia
Hypoaesthesia oral
Electrocardiogram abnormal x x
Feeling drunk
Terminal insomnia
Feeling jittery
Depressed level of consciousness
Sexual dysfunction
Breast pain female x x
Serum potassium decreased x
Presyncope
Diabetic peripheral neuropathy x x x x
White blood cell count decreased
Alkaline phosphatase serum increased x
Partial seizures
Ear and labyrinth disorders
Administration site reaction
Sleep disorder 0% - 2% x x x x x
Blood bicarbonate decreased
Lack of spontaneous speech
Disturbance in sexual arousal
Unresponsive to stimuli
Thromboembolic event x x x x x
Potassium low x
Raised liver function tests x
Circadian rhythm sleep disorder
Hypersomnia
Sluggishness
Crystal urine present
Ear discomfort
Musculoskeletal stiffness
Orgasmic sensation decreased
Dysphemia
Altered visual depth perception
Paranasal sinus hypersecretion
Tandem gait test abnormal
Unspecified disorder of autonomic nervous system x x x x x x x x x x x x x
Urticaria localised
Poor quality sleep
Epigastric discomfort
Calculus ureteric
Sudden unexplained death in epilepsy x x x x x
Suicidal behaviour x x x x x x
Hyposmia
Deafness unilateral
Mood alteration NOS x
Vaginal haemorrhage 0% - 3% x x x x x x x x x x
Loss of libido
Bleeding breakthrough x
Visual impairment x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TOPIRAMATE

Side effects:85
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:133
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:144
Source:FDA Structured Product Label

topiramate

Side effects:160
Source:FDA Structured Product Label

TOPIRAMATE / SANDOZ TOPIRAMATE

Side effects:170
Source:Health Canada

TOPIRAMATE / RATIO-TOPIRAMATE

Side effects:173
Source:Health Canada

TOPIRAMATE / CO TOPIRAMATE

Side effects:183
Source:Health Canada

TOPIRAMATE / TOPAMAX SPRINKLE CAPSULES 15MG

Side effects:192
Source:Health Canada

TOPIRAMATE / GEN-TOPIRAMATE

Side effects:198
Source:Health Canada

TOPIRAMATE

Side effects:207
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:231
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:242
Source:FDA Structured Product Label

topiramate

Side effects:242
Source:FDA Structured Product Label

topiramate

Side effects:243
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:243
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:244
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:244
Source:FDA Structured Product Label

TOPIRAMATE

Side effects:244
Source:FDA Structured Product Label

topiramate

Side effects:247
Source:FDA Structured Product Label

TOPIRAMATE / TOPAMAX SPRINKLE

Side effects:251
Source:FDA

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label